ASP Isotopes (ASPI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
25 Nov, 2025Executive summary
The 2025 Annual Meeting will be held virtually on December 18, 2025, to elect two Class III directors and ratify the appointment of the independent auditor.
Stockholders of record as of October 27, 2025, are entitled to vote; 110,840,122 shares of common stock are outstanding.
Proxy materials and the 2024 Annual Report are available online, with voting accessible via internet, phone, mail, or during the meeting.
Voting matters and shareholder proposals
Proposal 1: Election of Sipho N. Maseko and Todd Wider, M.D. as Class III directors for a three-year term until 2028.
Proposal 2: Ratification of EisnerAmper LLP as independent registered public accounting firm for fiscal year 2025.
Board recommends voting FOR both proposals; voting results will be announced at the meeting and filed with the SEC.
Stockholder proposals for the 2026 meeting must be received by August 3, 2026, for inclusion in proxy materials.
Board of directors and corporate governance
Board consists of seven members, six of whom are independent under Nasdaq standards; directors serve staggered three-year terms.
Board committees include audit, compensation, nominating and corporate governance, and a special projects committee.
Board leadership is provided by Executive Chairman Paul Mann, with Robert Ainscow as Interim CEO as of October 2025.
Board and committees met regularly in 2024, with all directors attending at least 75% of meetings.
Board considers diversity of background and experience in director nominations, though no formal diversity policy exists.
Latest events from ASP Isotopes
- Helium and isotope production ramp up amid global shortages, with major commercialization by 2026.ASPI
2nd Annual CG Virtual Sustainability Summit12 Mar 2026 - Expansion in isotopes, new contracts, and regulatory progress set up strong 2024 growth.ASPI
Emerging Growth Virtual Conference25 Feb 2026 - Pursuing global leadership in isotope supply with advanced enrichment tech and strategic expansion.ASPI
Corporate presentation4 Feb 2026 - Ytterbium-176 enrichment achieved; strong cash, plant ramp-up, and growth in isotope demand.ASPI
Q4 20244 Feb 2026 - Expanding isotope production, securing major contracts, and advancing HALEU for nuclear energy.ASPI
Emerging Growth Conference7711 Jan 2026 - Isotope enrichment firm seeks up to $100M in flexible offerings, with $25M at-the-market via Canaccord.ASPI
Registration Filing16 Dec 2025 - Shareholders will vote on director elections, a new equity plan, and auditor ratification at the 2024 meeting.ASPI
Proxy Filing2 Dec 2025 - Silicon-28 shipment, JSE listing, and Fermi MOU mark key advances in isotope and energy markets.ASPI
Status Update23 Nov 2025 - Q3 2025 delivered strong revenue growth, major contracts, and strategic expansion moves.ASPI
Q3 202521 Nov 2025